4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: January 24, 2019
Period of Report: January 18, 2019
Accession Number: 0001645627-19-000004

View Document ↗ View on SEC.gov ↗